Ultrasound salt aerosol inhalation study
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new way to deliver salt aerosol to the lungs using ultrasound, which may help people with chronic airway diseases like asthma or COPD. It aims to see how well the salt particles reach the lungs and if it's safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are a healthy volunteer or have a chronic airway disease that requires nebulizer treatment.
- You are not currently on a breathing machine (ventilator) and do not have a tracheostomy (artificial airway).
- You do not have severe liver or kidney problems.
- You are not allergic to radioactive elements (used in the study for imaging).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new inhaled medication (HRS-9821) to see if it is safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with COPD (chronic lung disease) to understand if it might help with breathing.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests whether breathing salt water vapor through a home nebulizer machine helps people with a specific type of lung infection (nontuberculous mycobacteria). The goal is to see if this simple treatment can improve breathing and reduce symptoms.
This trial tests whether inhaling a saltwater solution (hypertonic saline) twice a day for 12 weeks can help people with bronchiectasis who have a chronic cough and have had flare-ups in the past. It aims to see if this treatment reduces mucus and improves quality of life.
This trial tests whether giving inhaled salbutamol (a medication that opens airways) through a nebulizer can help people with pneumonia who are having trouble breathing and need oxygen support. It looks at how the treatment affects lung function and breathing effort.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.